They Beat Her Down Before Oct Options Expiration Next Friday
This was well timed and orchestrated with a relentless push down over the past couple of months. Japanese are very patient. Takeda has been around for over a century, intact and older than most big pharma companies. Mitsubishi and Mitsui been around for over 400 years. This type of thinking is very foreign to the Ameriican business mindset. They know what they have to do and it will take time. In the meantime, we have a gradual change of ownership. After next Friday and options expiration in January, it will be ore difficult for the shorts to hedge. They have more ego than money in the game at this point. I'm hanging tight.
Look, it may be impossible to bring O back to the market. However, Takeda is doing everything they can to find out the cause of the problem and to see if it can be remedied. They have hired advanced analytic firms to identify any chromatographic peaks that weren't discovered in the CMC section. The market they're addressing is very valuable. They have only one chance to convince the FDA to bring it back, so they're working methodically through the process. I'm down too, but some of this downward momentum is with the entire sector. Ariad's partial clinical hold didn't help much today. It brought back memories and an awareness of the risks in holding biotech stocks.